Navigation Links
Oncology Clinical Trials – The Paradigm Shift of Basket Trials: Key Considerations, Upcoming Webinar Hosted by Xtalks
Date:4/17/2019

Clinical trials of new cancer treatments have historically focused on disease type by tumor location: breast cancer, brain tumor, colon cancer and so on. With advances in medical oncology and genomic characterization of tumors, we are now able to test new therapies that target a single biomarker in multiple tumor types by conducting “basket trials.” This ability has created a paradigm shift in oncology trials.

In basket trials, cancers with differing histologies are pooled and the common element is a singular genetic mutation or protein alteration. The biomarker may be a protein or a DNA alteration. The tumors of interest are grouped in baskets for the analysis. The basket trial tests a drug that targets a common biologic process. Because of the different tumors involved, the recruiting physicians may represent many different areas of specialization.

Join Julia Lawrence, DO, Senior Medical Director and Head Oncologist at Synteract in a live session on Tuesday, May 7, 2019 at 11am EDT(4pm BST/UK) to learn about:

  • The differences between basket trials and historical oncology trials
  • Key parameters that should be considered during trial design
  • Understand the biomarker and the methodology used to test for it
  • How adaptive and flexible operational conduct from an experienced CRO study team allows for critical readiness to respond to inevitably shifting outcomes

For more information or to register for this event, visit Oncology Clinical Trials – The Paradigm Shift of Basket Trials: Key Considerations.

ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Read the full story at https://www.prweb.com/releases/oncology_clinical_trials_the_paradigm_shift_of_basket_trials_key_considerations_upcoming_webinar_hosted_by_xtalks/prweb16249240.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Bayer to Present New Data Across Oncology Portfolio at ASCO 2013
2. Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
3. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
4. Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
5. Leeds St Jamess Institute of Oncology Acquires Two Elekta Versa HD Radiotherapy Systems
6. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
7. Amgen To Webcast Investor Meeting At Upcoming American Society Of Clinical Oncology Annual Meeting
8. ViewRays Chief Medical Officer Honored by American Society for Radiation Oncology (ASTRO)
9. Genomic Health Announces Results of Ten Studies in Breast, Prostate and Colon Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting
10. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
11. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2019)... ... 2019 , ... Impact Advisors , a leading provider of clinical, revenue ... been named to Inc. magazine’s Inc. 5000 list. The Inc. 5000 list is a ... revenue growth. This year the firm was also named a 5-Time Inc. 5000 Honoree. ...
(Date:8/19/2019)... ... August 18, 2019 , ... Laurence Fishburne is a revered actor who has ... work spans genres and generations. On television, he has also put his skills to ... to today's world and gives viewers information in a fair and balanced way. Featuring ...
(Date:8/17/2019)... ... August 17, 2019 , ... ... 5000 , Foster Crown, LLC Ranks No. 2502 on the 2019 Inc. 5000 ... Foster Crown, LLC, the boutique physician recruitment firm is No. 2502 on its ...
Breaking Medicine Technology:
(Date:8/16/2019)... (PRWEB) , ... August 16, 2019 , ... ... revolutionize and standardize pharmaceutical and non-pharmaceutical cannabidiol (CBD) products across the CBD market ... set to launch its crowdfunding campaign to raise $50 million on September 9, ...
(Date:8/16/2019)... NEW HYDE PARK, N.Y. (PRWEB) , ... August ... ... proudly designed, fabricated, and donated a custom handcrafted, one-of-a-kind children’s aircraft to Ronald ... airplane was designed to give children residents undergoing medical treatments and their ...
(Date:8/16/2019)... ... August 16, 2019 , ... Dr. Demetri Arnaoutakis, a board-certified ... Beauty Network. , The Haute Beauty Network, well known for its exclusive and ... hair restoration expert and our newest addition to the Haute Beauty members-only network. ...
(Date:8/15/2019)... ... August 15, 2019 , ... The ASCP Foundation ... been directly affected by the closure of Hahnemann University Hospital in Philadelphia, which ... campaign, the ASCP Foundation will be making hardship grants of up to $2,500 ...
(Date:8/15/2019)... ... August 15, 2019 , ... ... "The deadline for family planning clinics to provide written assurance that they will ... Similar to the Global Gag Rule, the new policy restricts providers and ...
Breaking Medicine News(10 mins):